's stock had its "sell (d)" rating reaffirmed by equities research analysts at
Weiss Ratings in a research note issued on Wednesday,
Weiss Ratings reports.
Forian Stock Up 3.2%
NASDAQ:FORA opened at $2.27 on Wednesday. Forian has a 52 week low of $1.64 and a 52 week high of $4.03. The company has a market capitalization of $70.62 million, a P/E ratio of -25.22 and a beta of 1.03. The stock's fifty day moving average is $2.09 and its two-hundred day moving average is $2.04.
About Forian
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
